While Pliant Therapeutics and Acelyrin recently blocked ever-eager acquirer Concentra Biosciences with “poison pill” defenses ...

Tesla CEO Elon Musk is expected to step down from his position helming the federal Department of Government Efficiency (DOGE) ...

The cuts impact more than $2.4 billion in grant money, including $1.3 billion in grant money already spent on projects ...

British biotech CellCentric is settling into a new office in Boston, part of the company’s expansion into the U.S. as ...

The Trump administration is halting research funding to Princeton University and reviewing about $9 billion in federal grants and contracts to Harvard University, the latest escalation of the ...

Medtronic has inked a neurovascular partnership with Methinks AI, a Barcelona, Spain-based developer of programs to detect ...

Following the FDA clearance of its Versius robot last fall, CMR Surgical has posted another major funding round, raising more ...

FDA Chief Medical Officer Hilary Marston, M.D., is leaving her position at the agency.  | The FDA’s Chief Medical Officer ...

Across the study, two patients experienced “serious adverse events of atrial fibrillation (AF) requiring cardioversion,” ...

Sanofi has returned to Nurix Therapeutics for another autoimmune candidate, paying $15 million and committing up to $465 ...

The $150 million will also go toward Atsena’s preclinical pipeline and expand the use of the biotech’s spreading AAV.SPR ...

Cabaletta has been evaluating the CAR-T, called resecabtagene autoleucel or rese-cel , across six so-called RESET studies ...